nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—CA2—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0805	0.303	CbGpPWpGaD
Diazoxide—CA1—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0772	0.29	CbGpPWpGaD
Diazoxide—GLUL—gall bladder—colon cancer	0.0213	0.0557	CbGeAlD
Diazoxide—KCNMA1—blood vessel—colon cancer	0.021	0.055	CbGeAlD
Diazoxide—KCNMA1—gall bladder—colon cancer	0.0198	0.0517	CbGeAlD
Diazoxide—SLC12A3—renal system—colon cancer	0.0137	0.0359	CbGeAlD
Diazoxide—GLUL—embryo—colon cancer	0.0135	0.0353	CbGeAlD
Diazoxide—ATP1A1—gall bladder—colon cancer	0.0127	0.0332	CbGeAlD
Diazoxide—Herpes virus infection—Capecitabine—colon cancer	0.0118	0.0334	CcSEcCtD
Diazoxide—GLUL—epithelium—colon cancer	0.011	0.0288	CbGeAlD
Diazoxide—Emotional distress—Fluorouracil—colon cancer	0.011	0.0313	CcSEcCtD
Diazoxide—ATP1A1—Preimplantation Embryo—CDX2—colon cancer	0.011	0.0413	CbGpPWpGaD
Diazoxide—GLUL—smooth muscle tissue—colon cancer	0.0106	0.0278	CbGeAlD
Diazoxide—KCNMA1—epithelium—colon cancer	0.0102	0.0267	CbGeAlD
Diazoxide—GLUL—renal system—colon cancer	0.0102	0.0267	CbGeAlD
Diazoxide—Polyneuropathy—Capecitabine—colon cancer	0.01	0.0285	CcSEcCtD
Diazoxide—KCNMA1—smooth muscle tissue—colon cancer	0.00986	0.0258	CbGeAlD
Diazoxide—CA2—gall bladder—colon cancer	0.00974	0.0255	CbGeAlD
Diazoxide—KCNMA1—renal system—colon cancer	0.00949	0.0248	CbGeAlD
Diazoxide—Azotaemia—Vincristine—colon cancer	0.0094	0.0267	CcSEcCtD
Diazoxide—ABCC8—smooth muscle tissue—colon cancer	0.00919	0.024	CbGeAlD
Diazoxide—ABCC8—renal system—colon cancer	0.00884	0.0231	CbGeAlD
Diazoxide—GLUL—Amino acid and derivative metabolism—ODC1—colon cancer	0.00861	0.0324	CbGpPWpGaD
Diazoxide—GLUL—lymphoid tissue—colon cancer	0.00849	0.0222	CbGeAlD
Diazoxide—GLUL—digestive system—colon cancer	0.00839	0.0219	CbGeAlD
Diazoxide—Lacrimation—Irinotecan—colon cancer	0.00829	0.0236	CcSEcCtD
Diazoxide—ATP1A1—embryo—colon cancer	0.00806	0.0211	CbGeAlD
Diazoxide—KCNJ11—lymphoid tissue—colon cancer	0.00797	0.0208	CbGeAlD
Diazoxide—Lacrimation—Fluorouracil—colon cancer	0.00794	0.0226	CcSEcCtD
Diazoxide—GLUL—bone marrow—colon cancer	0.00773	0.0202	CbGeAlD
Diazoxide—GLUL—vagina—colon cancer	0.00741	0.0194	CbGeAlD
Diazoxide—CA1—renal system—colon cancer	0.00721	0.0188	CbGeAlD
Diazoxide—Ileus—Vincristine—colon cancer	0.00707	0.0201	CcSEcCtD
Diazoxide—Ileus—Irinotecan—colon cancer	0.00689	0.0196	CcSEcCtD
Diazoxide—ATP1A1—epithelium—colon cancer	0.00657	0.0172	CbGeAlD
Diazoxide—ATP1A1—smooth muscle tissue—colon cancer	0.00634	0.0166	CbGeAlD
Diazoxide—GLUL—liver—colon cancer	0.00625	0.0163	CbGeAlD
Diazoxide—CA2—embryo—colon cancer	0.00617	0.0161	CbGeAlD
Diazoxide—ATP1A1—renal system—colon cancer	0.0061	0.0159	CbGeAlD
Diazoxide—CA1—lymphoid tissue—colon cancer	0.00599	0.0156	CbGeAlD
Diazoxide—ABCC8—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	0.00595	0.0224	CbGpPWpGaD
Diazoxide—CA1—digestive system—colon cancer	0.00591	0.0155	CbGeAlD
Diazoxide—KCNMA1—liver—colon cancer	0.0058	0.0152	CbGeAlD
Diazoxide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	0.00577	0.0217	CbGpPWpGaD
Diazoxide—Hirsutism—Capecitabine—colon cancer	0.00562	0.016	CcSEcCtD
Diazoxide—CA1—bone marrow—colon cancer	0.00545	0.0142	CbGeAlD
Diazoxide—Drug interaction—Vincristine—colon cancer	0.0054	0.0154	CcSEcCtD
Diazoxide—Lacrimation increased—Irinotecan—colon cancer	0.00529	0.0151	CcSEcCtD
Diazoxide—Lacrimation increased—Fluorouracil—colon cancer	0.00507	0.0144	CcSEcCtD
Diazoxide—ATP1A1—lymphoid tissue—colon cancer	0.00506	0.0132	CbGeAlD
Diazoxide—CA2—epithelium—colon cancer	0.00504	0.0132	CbGeAlD
Diazoxide—ATP1A1—digestive system—colon cancer	0.005	0.0131	CbGeAlD
Diazoxide—CA2—smooth muscle tissue—colon cancer	0.00485	0.0127	CbGeAlD
Diazoxide—GLUL—lymph node—colon cancer	0.00479	0.0125	CbGeAlD
Diazoxide—Haemoglobin decreased—Capecitabine—colon cancer	0.00474	0.0135	CcSEcCtD
Diazoxide—CA2—renal system—colon cancer	0.00467	0.0122	CbGeAlD
Diazoxide—ATP1A1—bone marrow—colon cancer	0.00461	0.0121	CbGeAlD
Diazoxide—Ileus—Capecitabine—colon cancer	0.00461	0.0131	CcSEcCtD
Diazoxide—Azotaemia—Methotrexate—colon cancer	0.00456	0.013	CcSEcCtD
Diazoxide—KCNJ11—lymph node—colon cancer	0.0045	0.0118	CbGeAlD
Diazoxide—KCNMA1—lymph node—colon cancer	0.00445	0.0116	CbGeAlD
Diazoxide—ATP1A1—vagina—colon cancer	0.00442	0.0115	CbGeAlD
Diazoxide—CA1—liver—colon cancer	0.00441	0.0115	CbGeAlD
Diazoxide—ABCC8—ABC-family proteins mediated transport—ABCB1—colon cancer	0.00436	0.0164	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—TOP1—colon cancer	0.00432	0.0163	CbGpPWpGaD
Diazoxide—Ageusia—Capecitabine—colon cancer	0.00403	0.0115	CcSEcCtD
Diazoxide—CA2—lymphoid tissue—colon cancer	0.00388	0.0101	CbGeAlD
Diazoxide—CA2—digestive system—colon cancer	0.00383	0.01	CbGeAlD
Diazoxide—GLUL—TNF alpha Signaling Pathway—BAX—colon cancer	0.00381	0.0143	CbGpPWpGaD
Diazoxide—ATP1A1—liver—colon cancer	0.00373	0.00974	CbGeAlD
Diazoxide—Lacrimation increased—Capecitabine—colon cancer	0.00354	0.0101	CcSEcCtD
Diazoxide—CA2—bone marrow—colon cancer	0.00353	0.00924	CbGeAlD
Diazoxide—Cataract—Capecitabine—colon cancer	0.00343	0.00975	CcSEcCtD
Diazoxide—CA2—vagina—colon cancer	0.00338	0.00885	CbGeAlD
Diazoxide—CA1—lymph node—colon cancer	0.00338	0.00883	CbGeAlD
Diazoxide—GLUL—TNF alpha Signaling Pathway—BCL2L1—colon cancer	0.00331	0.0124	CbGpPWpGaD
Diazoxide—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00327	0.00931	CcSEcCtD
Diazoxide—Hypokalaemia—Irinotecan—colon cancer	0.00322	0.00916	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00319	0.00907	CcSEcCtD
Diazoxide—Fluid retention—Capecitabine—colon cancer	0.0031	0.00881	CcSEcCtD
Diazoxide—Pancreatitis—Irinotecan—colon cancer	0.003	0.00853	CcSEcCtD
Diazoxide—ATP1A1—Preimplantation Embryo—CDH1—colon cancer	0.00293	0.011	CbGpPWpGaD
Diazoxide—Eosinophilia—Fluorouracil—colon cancer	0.0029	0.00825	CcSEcCtD
Diazoxide—ATP1A1—lymph node—colon cancer	0.00286	0.00747	CbGeAlD
Diazoxide—CA2—liver—colon cancer	0.00286	0.00746	CbGeAlD
Diazoxide—Sweating—Vincristine—colon cancer	0.00269	0.00764	CcSEcCtD
Diazoxide—Vascular purpura—Capecitabine—colon cancer	0.00265	0.00753	CcSEcCtD
Diazoxide—Sweating—Irinotecan—colon cancer	0.00262	0.00744	CcSEcCtD
Diazoxide—GLUL—Metabolism—CA7—colon cancer	0.00261	0.00982	CbGpPWpGaD
Diazoxide—Haemoglobin—Irinotecan—colon cancer	0.00246	0.007	CcSEcCtD
Diazoxide—Purpura—Capecitabine—colon cancer	0.00246	0.00699	CcSEcCtD
Diazoxide—Haemorrhage—Irinotecan—colon cancer	0.00245	0.00697	CcSEcCtD
Diazoxide—Diplopia—Capecitabine—colon cancer	0.00237	0.00674	CcSEcCtD
Diazoxide—Haemoglobin—Fluorouracil—colon cancer	0.00236	0.00671	CcSEcCtD
Diazoxide—Haemorrhage—Fluorouracil—colon cancer	0.00235	0.00667	CcSEcCtD
Diazoxide—Flushing—Irinotecan—colon cancer	0.00227	0.00646	CcSEcCtD
Diazoxide—CA2—lymph node—colon cancer	0.00219	0.00572	CbGeAlD
Diazoxide—Hypokalaemia—Capecitabine—colon cancer	0.00216	0.00613	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00213	0.00607	CcSEcCtD
Diazoxide—Lymphadenopathy—Methotrexate—colon cancer	0.00207	0.00588	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—CASP3—colon cancer	0.00205	0.0077	CbGpPWpGaD
Diazoxide—Ill-defined disorder—Irinotecan—colon cancer	0.00198	0.00563	CcSEcCtD
Diazoxide—Abdominal discomfort—Capecitabine—colon cancer	0.00196	0.00558	CcSEcCtD
Diazoxide—Leukopenia—Vincristine—colon cancer	0.00196	0.00557	CcSEcCtD
Diazoxide—Vision blurred—Fluorouracil—colon cancer	0.00192	0.00547	CcSEcCtD
Diazoxide—Malaise—Irinotecan—colon cancer	0.00192	0.00547	CcSEcCtD
Diazoxide—Leukopenia—Irinotecan—colon cancer	0.00191	0.00543	CcSEcCtD
Diazoxide—Hypertension—Vincristine—colon cancer	0.00189	0.00538	CcSEcCtD
Diazoxide—Weight increased—Capecitabine—colon cancer	0.00186	0.0053	CcSEcCtD
Diazoxide—Hyperglycaemia—Capecitabine—colon cancer	0.00185	0.00525	CcSEcCtD
Diazoxide—Hypertension—Irinotecan—colon cancer	0.00184	0.00524	CcSEcCtD
Diazoxide—Leukopenia—Fluorouracil—colon cancer	0.00183	0.0052	CcSEcCtD
Diazoxide—Discomfort—Irinotecan—colon cancer	0.00179	0.0051	CcSEcCtD
Diazoxide—Oedema—Vincristine—colon cancer	0.00179	0.00508	CcSEcCtD
Diazoxide—Thrombocytopenia—Vincristine—colon cancer	0.00175	0.00498	CcSEcCtD
Diazoxide—Haematuria—Capecitabine—colon cancer	0.00174	0.00495	CcSEcCtD
Diazoxide—Oedema—Irinotecan—colon cancer	0.00174	0.00495	CcSEcCtD
Diazoxide—Chest pain—Fluorouracil—colon cancer	0.00174	0.00494	CcSEcCtD
Diazoxide—Hyperhidrosis—Vincristine—colon cancer	0.00173	0.00491	CcSEcCtD
Diazoxide—Discomfort—Fluorouracil—colon cancer	0.00172	0.00489	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—NRAS—colon cancer	0.00172	0.00645	CbGpPWpGaD
Diazoxide—Thrombocytopenia—Irinotecan—colon cancer	0.0017	0.00485	CcSEcCtD
Diazoxide—Anorexia—Vincristine—colon cancer	0.0017	0.00484	CcSEcCtD
Diazoxide—Hyperhidrosis—Irinotecan—colon cancer	0.00168	0.00478	CcSEcCtD
Diazoxide—Hypotension—Vincristine—colon cancer	0.00167	0.00475	CcSEcCtD
Diazoxide—Oedema—Fluorouracil—colon cancer	0.00167	0.00474	CcSEcCtD
Diazoxide—Anorexia—Irinotecan—colon cancer	0.00166	0.00472	CcSEcCtD
Diazoxide—Haemoglobin—Capecitabine—colon cancer	0.00165	0.00469	CcSEcCtD
Diazoxide—Haemorrhage—Capecitabine—colon cancer	0.00164	0.00466	CcSEcCtD
Diazoxide—CA2—Metabolism—CA7—colon cancer	0.00164	0.00615	CbGpPWpGaD
Diazoxide—Thrombocytopenia—Fluorouracil—colon cancer	0.00163	0.00464	CcSEcCtD
Diazoxide—Tachycardia—Fluorouracil—colon cancer	0.00163	0.00463	CcSEcCtD
Diazoxide—Hypotension—Irinotecan—colon cancer	0.00163	0.00462	CcSEcCtD
Diazoxide—Insomnia—Vincristine—colon cancer	0.00162	0.0046	CcSEcCtD
Diazoxide—Paraesthesia—Vincristine—colon cancer	0.0016	0.00456	CcSEcCtD
Diazoxide—Anorexia—Fluorouracil—colon cancer	0.00159	0.00452	CcSEcCtD
Diazoxide—GLUL—Metabolism—CHST5—colon cancer	0.00158	0.00595	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ODC1—colon cancer	0.00158	0.00595	CbGpPWpGaD
Diazoxide—Insomnia—Irinotecan—colon cancer	0.00157	0.00448	CcSEcCtD
Diazoxide—CA1—Metabolism—CA7—colon cancer	0.00157	0.0059	CbGpPWpGaD
Diazoxide—Paraesthesia—Irinotecan—colon cancer	0.00156	0.00444	CcSEcCtD
Diazoxide—Hypotension—Fluorouracil—colon cancer	0.00156	0.00443	CcSEcCtD
Diazoxide—Decreased appetite—Vincristine—colon cancer	0.00155	0.00442	CcSEcCtD
Diazoxide—Pain—Vincristine—colon cancer	0.00153	0.00435	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—TYMS—colon cancer	0.00152	0.00572	CbGpPWpGaD
Diazoxide—Flushing—Capecitabine—colon cancer	0.00152	0.00433	CcSEcCtD
Diazoxide—Decreased appetite—Irinotecan—colon cancer	0.00151	0.0043	CcSEcCtD
Diazoxide—Eosinophilia—Methotrexate—colon cancer	0.00151	0.00429	CcSEcCtD
Diazoxide—Insomnia—Fluorouracil—colon cancer	0.00151	0.00429	CcSEcCtD
Diazoxide—Paraesthesia—Fluorouracil—colon cancer	0.0015	0.00426	CcSEcCtD
Diazoxide—Pancreatitis—Methotrexate—colon cancer	0.00149	0.00425	CcSEcCtD
Diazoxide—Pain—Irinotecan—colon cancer	0.00149	0.00423	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—KRAS—colon cancer	0.00148	0.00556	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—BRAF—colon cancer	0.00147	0.00552	CbGpPWpGaD
Diazoxide—Abdominal discomfort—Methotrexate—colon cancer	0.00146	0.00416	CcSEcCtD
Diazoxide—Gastrointestinal pain—Vincristine—colon cancer	0.00146	0.00416	CcSEcCtD
Diazoxide—Decreased appetite—Fluorouracil—colon cancer	0.00145	0.00412	CcSEcCtD
Diazoxide—Feeling abnormal—Irinotecan—colon cancer	0.00143	0.00408	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—PTGS2—colon cancer	0.00143	0.00536	CbGpPWpGaD
Diazoxide—Pain—Fluorouracil—colon cancer	0.00142	0.00405	CcSEcCtD
Diazoxide—Gastrointestinal pain—Irinotecan—colon cancer	0.00142	0.00405	CcSEcCtD
Diazoxide—Body temperature increased—Vincristine—colon cancer	0.00141	0.00402	CcSEcCtD
Diazoxide—Abdominal pain—Vincristine—colon cancer	0.00141	0.00402	CcSEcCtD
Diazoxide—Body temperature increased—Irinotecan—colon cancer	0.00138	0.00391	CcSEcCtD
Diazoxide—Abdominal pain—Irinotecan—colon cancer	0.00138	0.00391	CcSEcCtD
Diazoxide—Feeling abnormal—Fluorouracil—colon cancer	0.00137	0.00391	CcSEcCtD
Diazoxide—Vision blurred—Capecitabine—colon cancer	0.00134	0.00382	CcSEcCtD
Diazoxide—ABCC8—Metabolism—CA7—colon cancer	0.00133	0.00502	CbGpPWpGaD
Diazoxide—Ill-defined disorder—Capecitabine—colon cancer	0.00132	0.00377	CcSEcCtD
Diazoxide—Body temperature increased—Fluorouracil—colon cancer	0.00132	0.00375	CcSEcCtD
Diazoxide—Hypersensitivity—Vincristine—colon cancer	0.00132	0.00374	CcSEcCtD
Diazoxide—Sweating—Methotrexate—colon cancer	0.0013	0.00371	CcSEcCtD
Diazoxide—Haematuria—Methotrexate—colon cancer	0.0013	0.00369	CcSEcCtD
Diazoxide—KCNJ11—Metabolism—CA7—colon cancer	0.00129	0.00486	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—CCND1—colon cancer	0.00129	0.00484	CbGpPWpGaD
Diazoxide—Malaise—Capecitabine—colon cancer	0.00129	0.00366	CcSEcCtD
Diazoxide—Hypersensitivity—Irinotecan—colon cancer	0.00128	0.00365	CcSEcCtD
Diazoxide—Asthenia—Vincristine—colon cancer	0.00128	0.00365	CcSEcCtD
Diazoxide—Leukopenia—Capecitabine—colon cancer	0.00128	0.00363	CcSEcCtD
Diazoxide—Palpitations—Capecitabine—colon cancer	0.00126	0.00359	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—HRAS—colon cancer	0.00126	0.00472	CbGpPWpGaD
Diazoxide—Asthenia—Irinotecan—colon cancer	0.00125	0.00355	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CDKN1A—colon cancer	0.00125	0.00469	CbGpPWpGaD
Diazoxide—Hypertension—Capecitabine—colon cancer	0.00123	0.0035	CcSEcCtD
Diazoxide—Hypersensitivity—Fluorouracil—colon cancer	0.00123	0.00349	CcSEcCtD
Diazoxide—Haemoglobin—Methotrexate—colon cancer	0.00123	0.00349	CcSEcCtD
Diazoxide—Diarrhoea—Vincristine—colon cancer	0.00122	0.00348	CcSEcCtD
Diazoxide—Haemorrhage—Methotrexate—colon cancer	0.00122	0.00347	CcSEcCtD
Diazoxide—Chest pain—Capecitabine—colon cancer	0.00121	0.00346	CcSEcCtD
Diazoxide—Anxiety—Capecitabine—colon cancer	0.00121	0.00344	CcSEcCtD
Diazoxide—Discomfort—Capecitabine—colon cancer	0.0012	0.00341	CcSEcCtD
Diazoxide—Diarrhoea—Irinotecan—colon cancer	0.00119	0.00339	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—EP300—colon cancer	0.00119	0.00446	CbGpPWpGaD
Diazoxide—Dizziness—Vincristine—colon cancer	0.00118	0.00336	CcSEcCtD
Diazoxide—Pruritus—Fluorouracil—colon cancer	0.00118	0.00335	CcSEcCtD
Diazoxide—Oedema—Capecitabine—colon cancer	0.00116	0.00331	CcSEcCtD
Diazoxide—Dizziness—Irinotecan—colon cancer	0.00115	0.00327	CcSEcCtD
Diazoxide—Diarrhoea—Fluorouracil—colon cancer	0.00114	0.00324	CcSEcCtD
Diazoxide—Thrombocytopenia—Capecitabine—colon cancer	0.00114	0.00324	CcSEcCtD
Diazoxide—Tachycardia—Capecitabine—colon cancer	0.00114	0.00323	CcSEcCtD
Diazoxide—Vomiting—Vincristine—colon cancer	0.00114	0.00323	CcSEcCtD
Diazoxide—Rash—Vincristine—colon cancer	0.00113	0.0032	CcSEcCtD
Diazoxide—Hyperhidrosis—Capecitabine—colon cancer	0.00113	0.0032	CcSEcCtD
Diazoxide—Dermatitis—Vincristine—colon cancer	0.00113	0.0032	CcSEcCtD
Diazoxide—GLUL—Neuronal System—BRAF—colon cancer	0.00112	0.00423	CbGpPWpGaD
Diazoxide—Headache—Vincristine—colon cancer	0.00112	0.00318	CcSEcCtD
Diazoxide—Anorexia—Capecitabine—colon cancer	0.00111	0.00316	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—NRAS—colon cancer	0.00111	0.00417	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—AKT1—colon cancer	0.00111	0.00417	CbGpPWpGaD
Diazoxide—Vomiting—Irinotecan—colon cancer	0.00111	0.00315	CcSEcCtD
Diazoxide—Dizziness—Fluorouracil—colon cancer	0.0011	0.00313	CcSEcCtD
Diazoxide—Rash—Irinotecan—colon cancer	0.0011	0.00312	CcSEcCtD
Diazoxide—Dermatitis—Irinotecan—colon cancer	0.0011	0.00312	CcSEcCtD
Diazoxide—Headache—Irinotecan—colon cancer	0.00109	0.0031	CcSEcCtD
Diazoxide—Hypotension—Capecitabine—colon cancer	0.00109	0.00309	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—PPARG—colon cancer	0.00108	0.00405	CbGpPWpGaD
Diazoxide—Nausea—Vincristine—colon cancer	0.00106	0.00302	CcSEcCtD
Diazoxide—Vomiting—Fluorouracil—colon cancer	0.00106	0.00301	CcSEcCtD
Diazoxide—Insomnia—Capecitabine—colon cancer	0.00105	0.003	CcSEcCtD
Diazoxide—Rash—Fluorouracil—colon cancer	0.00105	0.00299	CcSEcCtD
Diazoxide—Dermatitis—Fluorouracil—colon cancer	0.00105	0.00299	CcSEcCtD
Diazoxide—Paraesthesia—Capecitabine—colon cancer	0.00105	0.00297	CcSEcCtD
Diazoxide—Headache—Fluorouracil—colon cancer	0.00104	0.00297	CcSEcCtD
Diazoxide—Nausea—Irinotecan—colon cancer	0.00103	0.00294	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—MYC—colon cancer	0.00103	0.00389	CbGpPWpGaD
Diazoxide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.00102	0.00384	CbGpPWpGaD
Diazoxide—Decreased appetite—Capecitabine—colon cancer	0.00101	0.00288	CcSEcCtD
Diazoxide—Vision blurred—Methotrexate—colon cancer	0.001	0.00285	CcSEcCtD
Diazoxide—Pain—Capecitabine—colon cancer	0.000996	0.00283	CcSEcCtD
Diazoxide—CA2—Metabolism—CHST5—colon cancer	0.000991	0.00373	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ODC1—colon cancer	0.000991	0.00373	CbGpPWpGaD
Diazoxide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.000991	0.00373	CbGpPWpGaD
Diazoxide—Nausea—Fluorouracil—colon cancer	0.00099	0.00282	CcSEcCtD
Diazoxide—Ill-defined disorder—Methotrexate—colon cancer	0.000985	0.0028	CcSEcCtD
Diazoxide—Feeling abnormal—Capecitabine—colon cancer	0.00096	0.00273	CcSEcCtD
Diazoxide—Malaise—Methotrexate—colon cancer	0.000958	0.00272	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—KRAS—colon cancer	0.000955	0.00359	CbGpPWpGaD
Diazoxide—Gastrointestinal pain—Capecitabine—colon cancer	0.000952	0.00271	CcSEcCtD
Diazoxide—Leukopenia—Methotrexate—colon cancer	0.000951	0.0027	CcSEcCtD
Diazoxide—CA1—Metabolism—CHST5—colon cancer	0.00095	0.00357	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ODC1—colon cancer	0.00095	0.00357	CbGpPWpGaD
Diazoxide—Abdominal pain—Capecitabine—colon cancer	0.00092	0.00262	CcSEcCtD
Diazoxide—Body temperature increased—Capecitabine—colon cancer	0.00092	0.00262	CcSEcCtD
Diazoxide—Chest pain—Methotrexate—colon cancer	0.000904	0.00257	CcSEcCtD
Diazoxide—Discomfort—Methotrexate—colon cancer	0.000893	0.00254	CcSEcCtD
Diazoxide—Hypersensitivity—Capecitabine—colon cancer	0.000858	0.00244	CcSEcCtD
Diazoxide—Thrombocytopenia—Methotrexate—colon cancer	0.000849	0.00241	CcSEcCtD
Diazoxide—Hyperhidrosis—Methotrexate—colon cancer	0.000838	0.00238	CcSEcCtD
Diazoxide—Asthenia—Capecitabine—colon cancer	0.000835	0.00238	CcSEcCtD
Diazoxide—Anorexia—Methotrexate—colon cancer	0.000826	0.00235	CcSEcCtD
Diazoxide—Pruritus—Capecitabine—colon cancer	0.000824	0.00234	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—HRAS—colon cancer	0.000811	0.00305	CbGpPWpGaD
Diazoxide—Hypotension—Methotrexate—colon cancer	0.00081	0.0023	CcSEcCtD
Diazoxide—ABCC8—Metabolism—ODC1—colon cancer	0.000808	0.00304	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CHST5—colon cancer	0.000808	0.00304	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—BRAF—colon cancer	0.000808	0.00304	CbGpPWpGaD
Diazoxide—Diarrhoea—Capecitabine—colon cancer	0.000797	0.00227	CcSEcCtD
Diazoxide—Insomnia—Methotrexate—colon cancer	0.000784	0.00223	CcSEcCtD
Diazoxide—KCNJ11—Metabolism—ODC1—colon cancer	0.000783	0.00295	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CHST5—colon cancer	0.000783	0.00295	CbGpPWpGaD
Diazoxide—Paraesthesia—Methotrexate—colon cancer	0.000778	0.00221	CcSEcCtD
Diazoxide—Dizziness—Capecitabine—colon cancer	0.00077	0.00219	CcSEcCtD
Diazoxide—Decreased appetite—Methotrexate—colon cancer	0.000753	0.00214	CcSEcCtD
Diazoxide—Pain—Methotrexate—colon cancer	0.000741	0.00211	CcSEcCtD
Diazoxide—Vomiting—Capecitabine—colon cancer	0.00074	0.00211	CcSEcCtD
Diazoxide—Rash—Capecitabine—colon cancer	0.000734	0.00209	CcSEcCtD
Diazoxide—Dermatitis—Capecitabine—colon cancer	0.000733	0.00209	CcSEcCtD
Diazoxide—Headache—Capecitabine—colon cancer	0.000729	0.00207	CcSEcCtD
Diazoxide—Feeling abnormal—Methotrexate—colon cancer	0.000714	0.00203	CcSEcCtD
Diazoxide—Gastrointestinal pain—Methotrexate—colon cancer	0.000709	0.00202	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—EP300—colon cancer	0.000705	0.00265	CbGpPWpGaD
Diazoxide—Nausea—Capecitabine—colon cancer	0.000692	0.00197	CcSEcCtD
Diazoxide—Abdominal pain—Methotrexate—colon cancer	0.000685	0.00195	CcSEcCtD
Diazoxide—Body temperature increased—Methotrexate—colon cancer	0.000685	0.00195	CcSEcCtD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000676	0.00254	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000676	0.00254	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—HRAS—colon cancer	0.000675	0.00254	CbGpPWpGaD
Diazoxide—Hypersensitivity—Methotrexate—colon cancer	0.000639	0.00182	CcSEcCtD
Diazoxide—Asthenia—Methotrexate—colon cancer	0.000622	0.00177	CcSEcCtD
Diazoxide—Pruritus—Methotrexate—colon cancer	0.000613	0.00174	CcSEcCtD
Diazoxide—Diarrhoea—Methotrexate—colon cancer	0.000593	0.00169	CcSEcCtD
Diazoxide—ABCC8—Neuronal System—BRAF—colon cancer	0.000574	0.00216	CbGpPWpGaD
Diazoxide—Dizziness—Methotrexate—colon cancer	0.000573	0.00163	CcSEcCtD
Diazoxide—KCNJ11—Neuronal System—BRAF—colon cancer	0.000557	0.0021	CbGpPWpGaD
Diazoxide—Vomiting—Methotrexate—colon cancer	0.000551	0.00157	CcSEcCtD
Diazoxide—Rash—Methotrexate—colon cancer	0.000547	0.00155	CcSEcCtD
Diazoxide—Dermatitis—Methotrexate—colon cancer	0.000546	0.00155	CcSEcCtD
Diazoxide—Headache—Methotrexate—colon cancer	0.000543	0.00154	CcSEcCtD
Diazoxide—GLUL—Neuronal System—HRAS—colon cancer	0.000517	0.00194	CbGpPWpGaD
Diazoxide—Nausea—Methotrexate—colon cancer	0.000515	0.00146	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—TP53—colon cancer	0.000505	0.0019	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000456	0.00171	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ABCB1—colon cancer	0.000418	0.00157	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—TYMS—colon cancer	0.00041	0.00154	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—HRAS—colon cancer	0.000371	0.0014	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—EP300—colon cancer	0.000337	0.00127	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—SRC—colon cancer	0.000328	0.00123	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—VEGFA—colon cancer	0.000319	0.0012	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—NRAS—colon cancer	0.000315	0.00119	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TGFB1—colon cancer	0.000293	0.0011	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PPARG—colon cancer	0.000291	0.00109	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—KRAS—colon cancer	0.000271	0.00102	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—HRAS—colon cancer	0.000264	0.000993	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ABCB1—colon cancer	0.000262	0.000985	CbGpPWpGaD
Diazoxide—CA2—Metabolism—TYMS—colon cancer	0.000257	0.000967	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—HRAS—colon cancer	0.000256	0.000963	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ABCB1—colon cancer	0.000251	0.000944	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CA—colon cancer	0.000249	0.000938	CbGpPWpGaD
Diazoxide—CA1—Metabolism—TYMS—colon cancer	0.000247	0.000928	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TP53—colon cancer	0.000241	0.000907	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—HRAS—colon cancer	0.000231	0.000867	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTGS2—colon cancer	0.000229	0.00086	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ABCB1—colon cancer	0.000213	0.000803	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—TYMS—colon cancer	0.00021	0.000789	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ABCB1—colon cancer	0.000207	0.000779	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—AKT1—colon cancer	0.000204	0.000766	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—TYMS—colon cancer	0.000203	0.000765	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—EP300—colon cancer	0.00019	0.000715	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PPARG—colon cancer	0.000182	0.000685	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PPARG—colon cancer	0.000175	0.000657	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PPARG—colon cancer	0.000149	0.000559	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PPARG—colon cancer	0.000144	0.000542	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTGS2—colon cancer	0.000143	0.000539	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CA—colon cancer	0.000141	0.000529	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTGS2—colon cancer	0.000137	0.000517	CbGpPWpGaD
Diazoxide—CA2—Metabolism—EP300—colon cancer	0.000119	0.000448	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTGS2—colon cancer	0.000117	0.000439	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—AKT1—colon cancer	0.000115	0.000432	CbGpPWpGaD
Diazoxide—CA1—Metabolism—EP300—colon cancer	0.000114	0.00043	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTGS2—colon cancer	0.000113	0.000426	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—EP300—colon cancer	9.72e-05	0.000366	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—EP300—colon cancer	9.42e-05	0.000354	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CA—colon cancer	8.82e-05	0.000332	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CA—colon cancer	8.45e-05	0.000318	CbGpPWpGaD
Diazoxide—CA2—Metabolism—AKT1—colon cancer	7.2e-05	0.000271	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CA—colon cancer	7.19e-05	0.00027	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CA—colon cancer	6.97e-05	0.000262	CbGpPWpGaD
Diazoxide—CA1—Metabolism—AKT1—colon cancer	6.91e-05	0.00026	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—AKT1—colon cancer	5.87e-05	0.000221	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—AKT1—colon cancer	5.69e-05	0.000214	CbGpPWpGaD
